BCAB CIK: 1826892

BioAtla, Inc.

  • United States
  • Healthcare
  • Biotechnology
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25

Assets

(positive)
Change from FY21 to FY25
millions USD
FY21:
247
FY22:
220
FY23:
116
FY24:
51.2
FY25:
8.01
(positive)
Change from FY21 to FY25
millions USD
FY21:
7.13
FY22:
5.31
FY23:
3.25
FY24:
1.19
FY25:
5.82
Total assets
Change from FY21 to FY25
millions USD
FY21:
254
FY22:
226
FY23:
120
FY24:
52.4
FY25:
13.8

Liabilities & Equity

(negative)
Change from FY21 to FY25
millions USD
FY21:
19.8
FY22:
23.1
FY23:
28.3
FY24:
14.5
FY25:
21.9
(negative)
Change from FY21 to FY25
millions USD
FY21:
23.8
FY22:
22.3
FY23:
20.6
FY24:
23.6
FY25:
28.1
(positive)
Change from FY21 to FY25
millions USD
FY21:
211
FY22:
180
FY23:
70.7
FY24:
14.3
FY25:
−36.2
Total liabilities & equity
Change from FY21 to FY25
millions USD
FY21:
254
FY22:
226
FY23:
120
FY24:
52.4
FY25:
13.8

All amounts in millions USD Data sources:SEC EDGARTwelve Data